Furthermore, CompC or STO-609 pretreatment significantly decreased FoxO3a nuclear accumulation (Figure 6D) and FoxO3a phosphorylation (Figure 6E) in BMDMs treated with RES (without infection by T. gondii). Here, FOXO3 is linked to infection.